Synaptogenix Inc (SNPX)
5.09
+0.33
(+6.93%)
USD |
NASDAQ |
May 03, 16:00
5.05
-0.04
(-0.79%)
Pre-Market: 20:00
Synaptogenix 1 Year Total Returns (Daily): -75.91% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -75.91% |
May 02, 2024 | -77.30% |
May 01, 2024 | -77.27% |
April 30, 2024 | -78.70% |
April 29, 2024 | -79.99% |
April 26, 2024 | -79.87% |
April 25, 2024 | -80.81% |
April 24, 2024 | -80.80% |
April 23, 2024 | -81.15% |
April 22, 2024 | -82.02% |
April 19, 2024 | -82.68% |
April 18, 2024 | -79.74% |
April 17, 2024 | -77.96% |
April 16, 2024 | -78.37% |
April 15, 2024 | -79.44% |
April 12, 2024 | -77.68% |
April 11, 2024 | -77.27% |
April 10, 2024 | -76.79% |
April 09, 2024 | -74.67% |
April 08, 2024 | -72.36% |
April 05, 2024 | -75.19% |
April 04, 2024 | -77.09% |
April 03, 2024 | -77.50% |
April 02, 2024 | -77.01% |
April 01, 2024 | -77.03% |
Date | Value |
---|---|
March 28, 2024 | -77.14% |
March 27, 2024 | -77.05% |
March 26, 2024 | -76.14% |
March 25, 2024 | -77.97% |
March 22, 2024 | -76.61% |
March 21, 2024 | -76.23% |
March 20, 2024 | -75.47% |
March 19, 2024 | -74.71% |
March 18, 2024 | -76.39% |
March 15, 2024 | -76.58% |
March 14, 2024 | -80.24% |
March 13, 2024 | -80.45% |
March 12, 2024 | -80.56% |
March 11, 2024 | -80.22% |
March 08, 2024 | -82.80% |
March 07, 2024 | -81.74% |
March 06, 2024 | -81.15% |
March 05, 2024 | -81.69% |
March 04, 2024 | -82.08% |
March 01, 2024 | -80.15% |
February 29, 2024 | -79.67% |
February 28, 2024 | -79.73% |
February 27, 2024 | -81.39% |
February 26, 2024 | -82.51% |
February 23, 2024 | -84.19% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.40%
Minimum
Oct 27 2023
172.7%
Maximum
Dec 08 2021
-55.27%
Average
-78.68%
Median
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |
NovaBay Pharmaceuticals Inc | -90.79% |
Protalix BioTherapeutics Inc | -63.81% |